Shandong Buchang Pharmaceuticals Co. Ltd Financials

Market Capitalization CN¥18.24 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	-32.52
Forward PE
Price to Sales TTM	CN¥1.64
Price to Book MRQ	CN¥1.67
Enterprise to Revenue	1.68
Enterprise to EBITDA	15.11

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-3.23%
Operating Margin	14.59%
Return on Assets TTM	2.56%
Return on Equity TTM	-4.68%

Income Statement

Revenue TTM	CN¥11,150,184,448
Revenue per Share TTM	CN¥10.39
Quarterly Revenue Growth	5.50%
Gross Profit TTM	CN¥6,625,871,872
EBITDA	CN¥876,936,869
Net Income to Common TTM	CN¥-360,552,384
Diluted EPS TTM	CN¥-0.32
Quarterly Earnings Growth YoY	169.50%

Balance Sheet

Total Cash MRQ	CN¥2,140,230,784
Total Cash per Share MRQ	CN¥2.02
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	41.14
Current Ratio MRQ	1.14
Book Value per Share MRQ	CN¥9.90

Cash Flow

Operating Cash Flow TTM	CN¥1,543,851,904
Levered Free Cash Flow TTM	CN¥1,856,397,440

603858 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,106,042,645
Float Shares	408,474,935
Avg 10 Volume	3,721,517
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	58.99%
% Held by Institutions	4.11%

Stock Price Summary

Beta	0.47
Fifty Two Week Low	CN¥13.83
Fifty Two Week High	CN¥19.70
Fifty Two Week Change	9.51%
Day 50 MA	CN¥16.12
Day 200 MA	CN¥15.90

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.50
Forward Annual Dividend Yield	3.03%
Trailing Annual Dividend Rate	CN¥0.13
Trailing Annual Dividend Yield	0.76%
Payout Ratio	31.06%
Dividend Date
Ex Dividend Date	2024-08-20
Last Split Factor
Last Split Date	2019-08-19